4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-007557
Chief Commercial Officer sold 17,000 shares at an average $175.99 ($2,991,765)
- Chief Commercial Officer acquired 17,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CRUTCHFIELD BRADFORD · Chief Commercial Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 1 in the form | +17,000 | $1.16 | $19,720 | 51,608 | D |
| 2021-02-01 | Sale : show line 2 in the form | −746 | $173.99 | $129,796 | 50,862 | D |
| 2021-02-01 | Sale : show line 3 in the form | −4,003 | $175.25 | $701,522 | 46,859 | D |
| 2021-02-01 | Sale : show line 4 in the form | −8,451 | $175.94 | $1,486,839 | 38,408 | D |
| 2021-02-01 | Sale : show line 5 in the form | −2,700 | $176.94 | $477,751 | 35,708 | D |
| 2021-02-01 | Sale : show line 6 in the form | −900 | $177.86 | $160,073 | 34,808 | D |
| 2021-02-01 | Sale : show line 7 in the form | −200 | $178.92 | $35,783 | 34,608 | D |
| Open-market sales · 17,000 sh · avg $175.99 · $2,991,765 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −17,000 | $1.16 | 2027-02-03 | 17,000 | 596,000 | D |
Loading xslF345X03/doc4.xml…